文献速递脑血管病

重新审视急性缺血性卒中成功取栓后组织水平不完全再灌注

Revisiting Incomplete Tissue-Level Reperfusion Following Successful Thrombectomy for Acute Ischemic Stroke.
PubMed 文献 · Ann Neurol · 2026-01-26

本文综述急性缺血性卒中大血管成功再通(eTICI≥2b)后组织水平不完全再灌注的机制、评估与治疗。持续组织低灌注包括区域低灌注(远端栓塞)和缺血核心内毛细血管无复流,报告率在eTICI 3再通中为0-42.5%。持续低灌注与功能结局显著相关,但真正无复流的功能影响尚不明确。

要点

  • 成功再通后组织水平不完全再灌注发生率高,需灌注影像识别。
  • 区域低灌注源于远端栓塞,可24小时内自发逆转,与功能结局相关。
  • 真正无复流的功能影响不明,动脉溶栓可能主要作用于远端栓塞。

核心结论

  • 成功取栓后组织水平不完全再灌注是显著挑战,其机制包括区域低灌注和缺血核心内无复流。
  • 持续低灌注与功能结局显著相关,但真正无复流的功能影响尚不明确。

研究设计与样本

  • 综述,检索并汇总取栓后组织水平不完全再灌注的机制、评估方法和治疗策略的现有证据。

主要发现

  • 在血管造影完全再通(eTICI 3)患者中,报告的组织水平不完全再灌注率为0-42.5%。
  • 区域低灌注可在24小时内自发逆转,称为「延迟再灌注」。
  • 动脉溶栓随机对照试验中eTICI 2b患者功能获益更大,提示其可能作用于远端栓塞而非真正微血管功能障碍。

关键数值与推荐

  • 成功大血管再通定义为eTICI≥2b。
  • 组织水平不完全再灌注率在eTICI 3再通中报告为0-42.5%。

临床怎么用

  • 取栓后应关注灌注影像评估组织水平再灌注,而不仅依赖血管造影再通分级。
  • 对持续组织低灌注患者,可考虑动脉溶栓等针对远端栓塞的治疗策略。

局限性

  • 真正无复流的功能影响尚不明确。
  • 近期动脉溶栓随机对照试验缺乏灌注影像,无法区分远端栓塞与微血管功能障碍。
  • 组织水平不完全再灌注的定义不统一,导致报告率差异大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among patients with acute ischemic stroke achieving successful large vessel recanalization (defined as expanded Thrombolysis in Cerebral Infarction [eTICI ≥2b]), incomplete tissue-level reperfusion, distinct from visually identifiable distal occlusion on digital-subtraction angiography, remains a significant challenge. Persistent tissue-level hypoperfusion, identified on post-thrombectomy perfusion imaging, involves complex pathophysiology comprising 2 primary mechanisms: territorial hypoperfusion, stemming from distal emboli that often manifest after eTICI 2b to 2c or a posteriori with eTICI 3 recanalization, obstructing small distal arterial branches and forming wedge-shaped patterns; and hypoperfusion within the ischemic core, potentially representing capillary no-reflow, a phenomenon of microvascular perfusion failure despite successful macrovascular recanalization well described in the preclinical literature. Such pathophysiological differences have driven inconsistent designations, causing reported incomplete tissue-level reperfusion rate to vary widely (0-42.5%) even in angiographically complete (eTICI 3) recanalization. Further clouding the scene, territorial hypoperfusion may spontaneously reverse within 24 hours (termed "delayed reperfusion"), yet a distinct delayed hypoperfusion can affect necrotic tissue regardless of no-reflow. Whereas persistent hypoperfusion is significantly associated with functional outcomes, the functional impact of true no-reflow remains unclear. Recent positive randomized controlled trials (RCTs) of intra-arterial thrombolysis after successful recanalization offer a promising therapeutic strategy. However, these trials lacked perfusion imaging, whereas the larger functional benefit in patients achieving eTICI 2b suggests intra-arterial thrombolysis likely acted on distal emboli rather than true microvascular dysfunction. Regarding microvascular dysfunction, preclinical findings highlight potential therapeutic strategies such as targeting pericyte constriction or inflammatory responses, that warrant clinical translation. This review synthesizes current evidence on the mechanisms, assessment methods, and therapeutic strategies for addressing incomplete tissue-level reperfusion following thrombectomy. Further research is warranted to establish standardized definitions, develop targeted therapies for both territorial hypoperfusion and true no-reflow, and translate promising preclinical findings into effective clinical interventions. ANN NEUROL 2026;99:668-683.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Qiao Y, Ter Schiphorst A, Xu Y, et al. Revisiting Incomplete Tissue-Level Reperfusion Following Successful Thrombectomy for Acute Ischemic Stroke. Ann Neurol. 2026. PMID: 41586473. doi:10.1002/ana.78142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。